A clinical supply forecast is never static. Learn how to turn changing demand, constrained supply, and uncertainty into decisions that protect inventory and study continuity.
- AI Is Moving Clinical Supply From Forecasting To Real-Time Decision-Making
- One IP Receipt Problem Is An Exception. Four Is A Process.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Your IP Shipment Arrives At 07:00. Who Opens The Box?
- Segregation Of Duties: Drug Accountability Needs Three Separate Roles
- When Clinical Demand Becomes A Supply Plan
- Before The Excursion: The Governance Decisions That Should Already Be Made
- Clinical Trial Supply Chains Are Moving From Planning For Stability To Preparing For Uncertainty
ON-DEMAND WEBINARS
The COVID-19 global pandemic took the world by storm, disrupting several industries and our global supply chains. Learn why having a contingency plan and proactively planning gives a company a competitive edge.
Individual data points over time can provide precise drug dosing histories that enable better understanding of protocol adherence, safety, efficacy, PK/PD and a drug’s exposure-response relationship.
Want to know more about the growth and expansion of IRT in the decentralized trial space? Witness how IRT is being used to support direct-to-patient delivery in this hybrid trial case study.
This presentation explores practical pharmacy considerations in early-phase clinical trials, offering real-world insights from experienced clinical research pharmacists.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![clinical-trial-supply-challenges-GettyImages-2161372208]( "Managing Clinical Trial Supply Challenges In Complex Studies")
Managing Clinical Trial Supply Challenges In Complex StudiesComplex studies require flexible supply strategies that can adjust to shifting timelines, varied modalities, and global site needs. Adaptive, scalable planning helps lower risk.
-
![GettyImages-1070902452-planning-tracking-packaging-shipment]( "Winning The Race To FPI With Early Randomization And Trial Supply Management")
Winning The Race To FPI With Early Randomization And Trial Supply ManagementLearn why the ability to get investigational products to sites, and appropriately store them, is not a given – and this oversight can have serious consequences.
-
![GettyImages-1445871463 supply chain]( "A Guide To RTSM For Clinical Trials")
A Guide To RTSM For Clinical TrialsLooking ahead, the evolution of RTSM in clinical trials points towards cloud-based solutions, heightened emphasis on patient safety, and greater collaboration among stakeholders. Learn how you can prepare.
-
![Europe Globe Map Data GettyImages REV-1319209608]( "How Regional Logistics Strategy Supports Clinical Success In Europe")
How Regional Logistics Strategy Supports Clinical Success In EuropeIn an era where trial delays, customs bottlenecks, and fragmented regulations can derail even the most promising program, logistics has become a strategic asset.
-
![GettyImages-517118579 patient]( "Delivering Lifesaving Intravenous Therapy Across The USA Within 24 Hours")
Delivering Lifesaving Intravenous Therapy Across The USA Within 24 HoursThe goal was to successfully deliver time-critical intravenous therapy, Legalon, from a GMP Philadelphia depot to sites across the USA to treat patients suffering from amatoxin poisoning.
-
![iStock-635767756-clinical-trial-research]( "Building A Flexible, Challenge Resistant, Patient-Centric Clinical Supply Chain")
Building A Flexible, Challenge Resistant, Patient-Centric Clinical Supply ChainFlexible solutions, like demand-led supply and direct-to-patient distribution, are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies.
-
![iStock-1224887299-box-logistics-package]( "Clinical, Commercial Packaging: Delivering Next-Gen Therapies")
Clinical, Commercial Packaging: Delivering Next-Gen TherapiesSee how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.
-
![2026 start button-GettyImages-2232020388]( "How Life Sciences Leaders Are Preparing For More Curveballs In 2026")
How Life Sciences Leaders Are Preparing For More Curveballs In 2026Anticipate regulatory shifts and supply chain hurdles with agile scenario planning. Move beyond fragmented systems to build a resilient, data-driven foundation for a volatile industry landscape.
-
![GettyImages-1366016941 software]( "Rethinking RTSM Software: When Bigger Isn't Better")
Rethinking RTSM Software: When Bigger Isn't BetterDon’t let legacy vendor inertia jeopardize your trial. Discover why agility and deep RTSM expertise are the new benchmarks for reducing risk and ensuring precision in clinical operations.
-
![GettyImages-1184502868 oncology patient]( "Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial")
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology TrialUncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
